Larimar Therapeutics (LRMR) Earnings Date, Estimates & Call Transcripts → the harsh reality of the stock market (From DTI) (Ad) Free LRMR Stock Alerts $7.97 +0.10 (+1.27%) (As of 12:51 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (Mar. 14) -$0.30 Missed By -$0.05 Consensus EPS (Mar. 14) -$0.25 Get Larimar Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for LRMR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLRMR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LRMR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIThis is a huge income gap many folks can’t fill right nowThe average household has just north of $5,000 a month in expenses… I’m talking about things like healthcare, food, transportation… Clothing, electricity… Just the bare necessities. Meanwhile, the average monthly income in the United States is only $4,340 a month… If we’re being honest that’s a huge income gap many folks can’t fill right now… But that’s exactly why I’m on a mission… Watch me place one of these “2-step trades” live - before your very own eyes Larimar Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.30)($0.25)($0.28)Q2 20242($0.38)($0.30)($0.34)Q3 20242($0.47)($0.35)($0.41)Q4 20242($0.40)($0.39)($0.40)FY 20248($1.55)($1.29)($1.42)Q1 20252($0.47)($0.22)($0.35)Q2 20251($0.50)($0.50)($0.50)Q3 20251($0.64)($0.64)($0.64)Q4 20251($0.74)($0.74)($0.74)FY 20255($2.35)($2.10)($2.23)LRMR Earnings Date and InformationLarimar Therapeutics last posted its quarterly earnings results on March 14th, 2024. The reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.05. Larimar Therapeutics has generated ($0.97) earnings per share over the last year (($0.97) diluted earnings per share). Earnings for Larimar Therapeutics are expected to decrease in the coming year, from ($1.29) to ($2.22) per share. Larimar Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Larimar Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 3/14/2024Q4 2023($0.25)($0.30)($0.05)($0.30)--11/14/2023Q3 2023($0.23)($0.21)+$0.02($0.21)--8/10/2023Q2 2023($0.21)($0.19)+$0.02($0.19)--5/15/2023Q1 2023($0.25)($0.15)+$0.10($0.15)--3/14/2023Q4 2022($0.78)($0.21)+$0.57($0.21)--11/10/2022Q3 2022($0.50)($0.37)+$0.13($0.37)-- Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.62)($0.47)+$0.15($0.47)--5/12/2022Q1 2022($0.62)($0.49)+$0.13($0.49)--3/25/2022Q4 2021-($0.50)($0.50)($0.50)--11/12/2021Q3 2021($0.64)($0.92)($0.28)($0.92)--8/12/2021Q2 2021($0.75)($0.79)($0.04)($0.79)-- Larimar Therapeutics Earnings - Frequently Asked Questions When is Larimar Therapeutics's earnings date? Larimar Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on LRMR's earnings history. Did Larimar Therapeutics beat their earnings estimates last quarter? In the previous quarter, Larimar Therapeutics (NASDAQ:LRMR) missed the analysts' consensus estimate of ($0.25) by $0.05 with a reported earnings per share (EPS) of ($0.30). Learn more on analysts' earnings estimate vs. LRMR's actual earnings. How much profit does Larimar Therapeutics generate each year? Larimar Therapeutics (NASDAQ:LRMR) has a recorded net income of -$36.95 million. LRMR has generated -$0.97 earnings per share over the last four quarters. What is Larimar Therapeutics's EPS forecast for next year? Larimar Therapeutics's earnings are expected to decrease from ($1.29) per share to ($2.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies: VERV Earnings ALT Earnings KALV Earnings TVTX Earnings OCS Earnings STTK Earnings CMPS Earnings ABUS Earnings ATXS Earnings APLT Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:LRMR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldGold ManiaStansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.